Honokiol is a small molecule inhibitor that binds to the transactivation domain of FOXM1 and inhibits FOXM transcriptional activity by preventing its binding to DNA, leading to the suppression of cell proliferation of breast, lung, pancreatic, and prostate cancers. This evidence concerns the gene FOXM1 and prostate carcinoma.